The NHance® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.

Saved in:
Bibliographic Details
Title: The NHance® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.
Authors: Aftimos P; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium., Rolfo C; University Hospital Antwerp, 2650 Edegem, Belgium., Rottey S; University Hospital Ghent, 9000 Ghent, Belgium., Barthélémy P; Medical Oncology Unit, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France., Borg C; Medical Oncology Department, University Hospital of Besançon, CEDEX, 25000 Besançon, France., Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea., Oh DY; Seoul National University Hospital, Seoul 03080, Korea., Kim SW; Asan Medical Center, Department of Oncology, University of Ulsan College of Medicine, Seoul 05505, Korea., De Jonge N; Argenx BV, Industriepark Zwijnaarde 7, 9052 Ghent, Belgium., Hanssens V; Argenx BV, Industriepark Zwijnaarde 7, 9052 Ghent, Belgium., Zwanenpoel K; University Hospital Antwerp, 2650 Edegem, Belgium., Molthoff C; Department of Radiology & Nuclear Medicine, VU University Medical Center Amsterdam, 1012 Amsterdam, The Netherlands., Vugts D; Department of Radiology & Nuclear Medicine, VU University Medical Center Amsterdam, 1012 Amsterdam, The Netherlands., Dreier T; Argenx BV, Industriepark Zwijnaarde 7, 9052 Ghent, Belgium.; AgomAb Therapeutics NV, 9000 Ghent, Belgium., Verheesen P; Argenx BV, Industriepark Zwijnaarde 7, 9052 Ghent, Belgium., van Dongen GAMS; Department of Radiology & Nuclear Medicine, VU University Medical Center Amsterdam, 1012 Amsterdam, The Netherlands., Jacobs J; Argenx BV, Industriepark Zwijnaarde 7, 9052 Ghent, Belgium., Van Rompaey L; Argenx BV, Industriepark Zwijnaarde 7, 9052 Ghent, Belgium., Hultberg A; Argenx BV, Industriepark Zwijnaarde 7, 9052 Ghent, Belgium., Michieli P; AgomAb Therapeutics NV, 9000 Ghent, Belgium.; Department of Oncology, University of Torino Medical School, 10124 Turin, Italy., Pauwels P; University Hospital Antwerp, 2650 Edegem, Belgium., Fung S; Argenx BV, Industriepark Zwijnaarde 7, 9052 Ghent, Belgium., Thibault A; Argenx BV, Industriepark Zwijnaarde 7, 9052 Ghent, Belgium., de Haard H; Argenx BV, Industriepark Zwijnaarde 7, 9052 Ghent, Belgium., Leupin N; Argenx BV, Industriepark Zwijnaarde 7, 9052 Ghent, Belgium., Awada A; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium.
Source: Biomedicines [Biomedicines] 2021 Jun 10; Vol. 9 (6). Date of Electronic Publication: 2021 Jun 10.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2227-9059
DOI:10.3390/biomedicines9060665